11 – 12 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2008
-
Mark
IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS
2008) 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases In Hepatology 48(4). p.1875-1875(
- Contribution to journal › Published meeting abstract
-
Mark
Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »